Latest Health Discovery Cp (HDVY) Headlines T
Post# of 302
Posted On: 03/10/2014 2:51:52 AM
Latest Health Discovery Cp (HDVY) Headlines
Time Warner Cable and Discovery Communications Reach Long-Term Distribution Agreement
Business Wire - Mon Nov 18, 9:00AM CST
Time Warner Cable and Discovery Communications today announced the early renewal of their distribution agreement, which will allow Time Warner Cable and Bright House Networks to continue delivery of Discovery's networks to their subscribers without interruption.
Former U.S. Secretary of Transportation and Former U.S. Secretary of Commerce Joins Health Discovery Corporation Board of Directors
Business Wire - Wed May 15, 4:44PM CDT
Health Discovery Corporation (OTCBB: HDVY) announced today that Secretary Norman Mineta has joined Health Discovery Corporation's Board of Directors.
Personalized Medicine Market Potential
M2 - Fri Mar 08, 10:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/qp4lcw/personalized) has announced the addition of the "Personalized Medicine Market Potential" report to their offering. Genetics has changed the face of the pharmaceutical industry today. With advances in the field of genetics, it is now possible to customize even your medicines according to your genetic constitution. The emergence of personalized medicines has taken the pharmaceutical industry by storm. With genetics making it possible to personalize your medicines, it has now become possible to tailor medicines to cure diseases such as cancer, sinusitis and scientists are looking at options for curing AIDS as well with personalized medicines. Often described as the right treatment for the right person at the right time, personalized medicines however face many challenges before they become widely available, the biggest challenge being regulatory hurdles and cost. This report is a comprehensive analysis of the Personalized Medicines mark
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Business Wire - Thu Dec 27, 9:48AM CST
Health Discovery Corporation (OTCBB: HDVY) announced today that on December 18, 2012, the Board of Directors appointed Dr. John Norris as its new CEO. He succeeds Dr. Stephen Barnhill, who founded HDC, served as Chairman and CEO for 9 years and brought the Company to profitability in Q3 2012.
Molecular Diagnostics - Global Strategic Business Report
M2 - Fri Dec 21, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/3zps7t/molecular) has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following Product Segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 103 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Life Technologies Corporation, Celera, Biom?rieux, CytoCore Inc., ELITech Group, GE Healthcare, Genzyme Corporation, Hologic, Inc., Laboratory Corporation of America? Holdings, MiraiBio, Inc., Novartis Diagnostics, QIAGEN N. V, Quest Diagnostics, In
Time Warner Cable and Discovery Communications Reach Long-Term Distribution Agreement
Business Wire - Mon Nov 18, 9:00AM CST
Time Warner Cable and Discovery Communications today announced the early renewal of their distribution agreement, which will allow Time Warner Cable and Bright House Networks to continue delivery of Discovery's networks to their subscribers without interruption.
Former U.S. Secretary of Transportation and Former U.S. Secretary of Commerce Joins Health Discovery Corporation Board of Directors
Business Wire - Wed May 15, 4:44PM CDT
Health Discovery Corporation (OTCBB: HDVY) announced today that Secretary Norman Mineta has joined Health Discovery Corporation's Board of Directors.
Personalized Medicine Market Potential
M2 - Fri Mar 08, 10:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/qp4lcw/personalized) has announced the addition of the "Personalized Medicine Market Potential" report to their offering. Genetics has changed the face of the pharmaceutical industry today. With advances in the field of genetics, it is now possible to customize even your medicines according to your genetic constitution. The emergence of personalized medicines has taken the pharmaceutical industry by storm. With genetics making it possible to personalize your medicines, it has now become possible to tailor medicines to cure diseases such as cancer, sinusitis and scientists are looking at options for curing AIDS as well with personalized medicines. Often described as the right treatment for the right person at the right time, personalized medicines however face many challenges before they become widely available, the biggest challenge being regulatory hurdles and cost. This report is a comprehensive analysis of the Personalized Medicines mark
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Business Wire - Thu Dec 27, 9:48AM CST
Health Discovery Corporation (OTCBB: HDVY) announced today that on December 18, 2012, the Board of Directors appointed Dr. John Norris as its new CEO. He succeeds Dr. Stephen Barnhill, who founded HDC, served as Chairman and CEO for 9 years and brought the Company to profitability in Q3 2012.
Molecular Diagnostics - Global Strategic Business Report
M2 - Fri Dec 21, 8:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/3zps7t/molecular) has announced the addition of the "Molecular Diagnostics - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Molecular Diagnostics in US$ million by the following Product Segments: Infectious Disease Testing, Pharmacogenomics, and Cancer Screening. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. A six-year historic analysis is also provided for these markets. The report profiles 103 companies including many key and niche players such as Abbott Laboratories, Abbott Molecular, Life Technologies Corporation, Celera, Biom?rieux, CytoCore Inc., ELITech Group, GE Healthcare, Genzyme Corporation, Hologic, Inc., Laboratory Corporation of America? Holdings, MiraiBio, Inc., Novartis Diagnostics, QIAGEN N. V, Quest Diagnostics, In
(0)
(0)